SUSQUEHANNA INTERNATIONAL GROUP, LLP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,021,591
+12.9%
34,819
+4.6%
0.00%
Q2 2023$1,791,193
+35.4%
33,275
-0.1%
0.00%
Q1 2023$1,323,192
+2.5%
33,313
+3.8%
0.00%
Q4 2022$1,291,383
-55.0%
32,100
-64.0%
0.00%
Q3 2022$2,869,000
+12.7%
89,265
+4.0%
0.00%
Q2 2022$2,545,000
-10.6%
85,799
-15.3%
0.00%
Q1 2022$2,846,000
-61.2%
101,272
-36.4%
0.00%
Q4 2021$7,336,000
+437.0%
159,200
+282.3%
0.00%
Q3 2021$1,366,000
+49.6%
41,648
+60.0%
0.00%
Q2 2021$913,000
+20.9%
26,037
+24.6%
0.00%
Q1 2021$755,000
-32.3%
20,900
-45.6%
0.00%
Q4 2020$1,116,000
+0.2%
38,400
-2.7%
0.00%
Q3 2020$1,114,000
-59.7%
39,465
-53.8%
0.00%
Q2 2020$2,763,000
+9.6%
85,449
+38.1%
0.00%
Q1 2020$2,522,000
-29.8%
61,886
+6.3%
0.00%
-100.0%
Q4 2019$3,592,000
-59.0%
58,239
-51.6%
0.00%
-66.7%
Q3 2019$8,763,000
-60.4%
120,254
-55.3%
0.00%0.0%
Q2 2019$22,114,000
+477.8%
269,002
+395.8%
0.00%
+50.0%
Q1 2019$3,827,000
+163.9%
54,257
+68.4%
0.00%
Q4 2018$1,450,000
-21.6%
32,213
-1.5%
0.00%
Q3 2018$1,849,000
-70.6%
32,700
-65.2%
0.00%
-100.0%
Q2 2018$6,286,000
-36.2%
94,100
-44.4%
0.00%
-50.0%
Q1 2018$9,857,000
+48.5%
169,300
+64.4%
0.00%
+100.0%
Q4 2017$6,638,000
+48.1%
103,000
+20.7%
0.00%
+100.0%
Q3 2017$4,481,000
+20.1%
85,370
+7.1%
0.00%0.0%
Q2 2017$3,731,000
-49.9%
79,739
-47.0%
0.00%
-75.0%
Q1 2017$7,444,000
-21.2%
150,351
-3.6%
0.00%
-20.0%
Q4 2016$9,450,000
-37.8%
155,885
-32.0%
0.01%
-28.6%
Q3 2016$15,201,000
+23.1%
229,108
+3.6%
0.01%0.0%
Q2 2016$12,348,000
+5.2%
221,219
-36.6%
0.01%
+16.7%
Q1 2016$11,739,000
-43.8%
348,780
-24.6%
0.01%
-33.3%
Q4 2015$20,881,000
+173.7%
462,729
+139.6%
0.01%
+200.0%
Q3 2015$7,630,000
-31.3%
193,123
+7.9%
0.00%
-40.0%
Q2 2015$11,107,000
+200.4%
179,000
+202.9%
0.01%
+150.0%
Q1 2015$3,697,000
+475.0%
59,101
+418.9%
0.00%
Q4 2014$643,000
+2.4%
11,390
-37.6%
0.00%
Q2 2014$628,000
-17.7%
18,244
-25.0%
0.00%
Q1 2014$763,000
-90.2%
24,326
-93.7%
0.00%
-100.0%
Q4 2013$7,783,000
+106.2%
387,600
+0.3%
0.00%
+50.0%
Q3 2013$3,774,000386,3000.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders